RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines
The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genome.
Useful takeaways from this story.
The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genome.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genome.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.